XTL Net Tangible Assets vs Capital Surpluse Analysis

XTLB Stock  USD 1.80  0.10  5.88%   
XTL Biopharmaceutica financial indicator trend analysis is more than just analyzing XTL Biopharmaceuticals current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether XTL Biopharmaceuticals is a good investment. Please check the relationship between XTL Biopharmaceutica Net Tangible Assets and its Capital Surpluse accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XTL Biopharmaceuticals Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Net Tangible Assets vs Capital Surpluse

Net Tangible Assets vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of XTL Biopharmaceuticals Net Tangible Assets account and Capital Surpluse. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between XTL Biopharmaceutica's Net Tangible Assets and Capital Surpluse is -0.13. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of XTL Biopharmaceuticals Ltd, assuming nothing else is changed. The correlation between historical values of XTL Biopharmaceutica's Net Tangible Assets and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of XTL Biopharmaceuticals Ltd are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Net Tangible Assets i.e., XTL Biopharmaceutica's Net Tangible Assets and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

-0.13
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Capital Surpluse

Most indicators from XTL Biopharmaceutica's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into XTL Biopharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XTL Biopharmaceuticals Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At present, XTL Biopharmaceutica's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 3.9 M, whereas Selling General Administrative is forecasted to decline to about 697.3 K.

XTL Biopharmaceutica fundamental ratios Correlations

1.0-0.21-0.980.740.840.87-0.10.99-0.420.980.970.430.150.050.940.86-0.580.970.230.210.980.95-0.570.99-0.06
1.0-0.19-0.980.690.810.85-0.080.99-0.430.970.960.430.10.060.940.86-0.560.970.210.250.990.95-0.550.99-0.12
-0.21-0.190.24-0.3-0.21-0.25-0.05-0.130.4-0.27-0.17-0.42-0.25-0.03-0.26-0.20.51-0.19-0.22-0.24-0.11-0.280.54-0.13-0.19
-0.98-0.980.24-0.72-0.8-0.840.07-0.980.36-0.97-0.96-0.36-0.12-0.14-0.9-0.850.6-0.95-0.25-0.23-0.98-0.910.59-0.980.15
0.740.69-0.3-0.720.690.730.010.71-0.280.720.720.290.29-0.030.670.64-0.490.70.5-0.140.690.68-0.490.710.14
0.840.81-0.21-0.80.690.890.020.82-0.220.840.830.220.46-0.080.680.61-0.670.740.10.150.80.71-0.650.820.3
0.870.85-0.25-0.840.730.89-0.250.87-0.150.910.930.160.570.070.680.87-0.810.740.030.060.830.71-0.790.870.36
-0.1-0.08-0.050.070.010.02-0.25-0.08-0.28-0.13-0.20.28-0.5-0.380.0-0.350.08-0.070.440.3-0.040.00.06-0.08-0.28
0.990.99-0.13-0.980.710.820.87-0.08-0.330.980.980.330.130.10.890.87-0.60.940.190.221.00.9-0.581.0-0.11
-0.42-0.430.40.36-0.28-0.22-0.15-0.28-0.33-0.31-0.22-1.00.360.55-0.66-0.280.01-0.49-0.4-0.42-0.36-0.650.04-0.330.13
0.980.97-0.27-0.970.720.840.91-0.130.98-0.310.990.310.260.180.860.89-0.710.910.160.180.960.88-0.70.98-0.02
0.970.96-0.17-0.960.720.830.93-0.20.98-0.220.990.220.310.210.820.91-0.70.890.130.140.960.84-0.680.980.01
0.430.43-0.42-0.360.290.220.160.280.33-1.00.310.22-0.36-0.540.660.28-0.020.490.40.420.360.65-0.060.33-0.13
0.150.1-0.25-0.120.290.460.57-0.50.130.360.260.31-0.360.22-0.10.28-0.59-0.02-0.25-0.310.05-0.07-0.590.130.81
0.050.06-0.03-0.14-0.03-0.080.07-0.380.10.550.180.21-0.540.22-0.10.13-0.210.03-0.03-0.350.09-0.11-0.20.1-0.33
0.940.94-0.26-0.90.670.680.680.00.89-0.660.860.820.66-0.1-0.10.75-0.350.980.370.280.911.0-0.350.89-0.22
0.860.86-0.2-0.850.640.610.87-0.350.87-0.280.890.910.280.280.130.75-0.650.790.10.120.840.77-0.630.870.08
-0.58-0.560.510.6-0.49-0.67-0.810.08-0.60.01-0.71-0.7-0.02-0.59-0.21-0.35-0.65-0.410.15-0.25-0.55-0.391.0-0.6-0.36
0.970.97-0.19-0.950.70.740.74-0.070.94-0.490.910.890.49-0.020.030.980.79-0.410.320.210.950.98-0.40.94-0.22
0.230.21-0.22-0.250.50.10.030.440.19-0.40.160.130.4-0.25-0.030.370.10.150.32-0.180.210.350.120.19-0.27
0.210.25-0.24-0.23-0.140.150.060.30.22-0.420.180.140.42-0.31-0.350.280.12-0.250.21-0.180.240.28-0.250.22-0.19
0.980.99-0.11-0.980.690.80.83-0.041.0-0.360.960.960.360.050.090.910.84-0.550.950.210.240.92-0.531.0-0.19
0.950.95-0.28-0.910.680.710.710.00.9-0.650.880.840.65-0.07-0.111.00.77-0.390.980.350.280.92-0.390.9-0.18
-0.57-0.550.540.59-0.49-0.65-0.790.06-0.580.04-0.7-0.68-0.06-0.59-0.2-0.35-0.631.0-0.40.12-0.25-0.53-0.39-0.58-0.36
0.990.99-0.13-0.980.710.820.87-0.081.0-0.330.980.980.330.130.10.890.87-0.60.940.190.221.00.9-0.58-0.11
-0.06-0.12-0.190.150.140.30.36-0.28-0.110.13-0.020.01-0.130.81-0.33-0.220.08-0.36-0.22-0.27-0.19-0.19-0.18-0.36-0.11
Click cells to compare fundamentals

XTL Biopharmaceutica Account Relationship Matchups

XTL Biopharmaceutica fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets7.2M6.5M6.6M4.2M2.4M2.3M
Total Stockholder Equity7.0M6.2M5.3M4.0M2.2M2.1M
Liabilities And Stockholders Equity7.2M6.5M6.6M4.2M2.4M2.3M
Total Liab232K254K1.3M187K206K195.7K
Other Current Liab231K252K229K185K205K194.8K
Total Current Liabilities232K254K231K187K206K195.7K
Other Liab1.0M465K2.6M1.1M1.2M1.3M
Net Debt(4.5M)(3.6M)(3.0M)(2.1M)(1.4M)(1.5M)
Retained Earnings(153.9M)(154.7M)(155.1M)(156.5M)(158.2M)(166.2M)
Cash4.5M3.6M3.0M2.1M1.4M1.3M
Cash And Short Term Investments6.7M6.0M6.1M3.7M2.0M1.9M
Short Term Investments2.3M2.4M3.2M1.6M605K574.8K
Non Current Liabilities Total2.7M0.01K2.6M1.1M2K
Other Current Assets102K79K110K85K40K68K
Total Current Assets6.8M6.1M6.2M3.8M2.0M1.9M
Net Tangible Assets6.6M3.2M5.0M3.6M4.2M4.6M
Net Invested Capital7.0M6.2M5.3M4.0M2.2M4.2M
Net Working Capital6.6M5.9M6.0M3.6M1.8M1.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether XTL Biopharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of XTL Biopharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xtl Biopharmaceuticals Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xtl Biopharmaceuticals Ltd Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XTL Biopharmaceuticals Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XTL Biopharmaceutica. If investors know XTL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XTL Biopharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Earnings Share
(0.03)
Return On Assets
(0.14)
Return On Equity
(0.13)
The market value of XTL Biopharmaceuticals is measured differently than its book value, which is the value of XTL that is recorded on the company's balance sheet. Investors also form their own opinion of XTL Biopharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is XTL Biopharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XTL Biopharmaceutica's market value can be influenced by many factors that don't directly affect XTL Biopharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.